ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000444.1|Thaxtomin_1 # 1 # 1203 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000444.1|Thaxtomin_1 	1	1203	-	Loose	500	25.7942	GIL-1	31.67	3006888	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	GIL beta-lactamase	GTGACTTTCGAAGTCGCCCTGGGCCCTTCCTTGCCCGCCCCGTCCCCGACAGCGTGCCCGGCGCTGGCGCACGATTCGCCCCTCAGTCCCGTCCCGTCGGCGGAACCGGCGACGTCGCAGGACTGCGGCGTCGCCGATCCAGACGAGGCCGAGGAGTTCCTGCGCCAGTTTCACGCGGAGCAGTCCGACCAGGCCGTCCCGCTCACTCGGCGCCTGGACCAGGTTCGCGCTGCCATCGACGCCACGGGCACCTACCGTCATACCACCGCCGAGCTCGTGTTCGGTGCCCGTGTCGCGTGGCGCAACTCCAGTCGCTGTATCGGCCGCCTGTACTGGAACAGCCTGCGCGTCCTGGACCGCCGGGACACCACAGCCCCCGAGGTAATCCACCGGCACCTTTGCACGCACCTGCGCCAGGCGACCAACGGTGGGCGTATCAGGCCGGTGATTTCGGTCTTCGCCCCGGACGCACCCAGCCGACCCGGCCCGCGGGTGTGGAACGAGCAACTCGTCCGGTACGCCGGCCACCGTCGCGACGACGGCACCGTACTCGGCGACCCGCGATCTGCCGACCTCACCGAGGCCATCCGCGGCCTCGGATGGCAGGGAGGCCGCCAAGGGCCGTTCGACGTCCTGCCCCTGGTCATCGACGCCCACGACGACAAACCGCGGTTCTTCGAGCTGCCGCGGGAGGTTGTCCTGGAGGTCCCTATCACCCACCCCGACGTCCCACGACTGGCCGAACTCTGCCTGCGCTGGCACGCCGTACCCGTTATCTCCAACATGCGCCTGCGTATCGGCGGGGTGGACTACCCCCTCGCCCCGTTCAACGGCTGGTACATGGGCACGGAGATCGGCGTCCGTAACCTCGTCGACGAGGCCCGCTACAACCTGCTCCCCGCCGTGGCCGCCTGCCTCCAGTTGGACACCACCAGCGAGTCCACCCTGTGGCGTGACCGCGCTCTGGTCGAACTCAACGTTGCCGTCTTGCACTCTTTCGCGGCCGCAGGCGTCCGGATCAGTGACCACCACGAGGAGTCCCGGCGCTTCCTCGCCCACCTGACCAAGGAGGAACGCCAGGGCCGCACCGTACCCGCGGACTGGAGCTGGATCGTCCCTCCGCTTTCCAGCGGCATCACCCCCGTCTTCCACCGCTACTACGACAACGCCGACCAGCGCCCCAACTTTTACCCTCATCAGTGA	MTFEVALGPSLPAPSPTACPALAHDSPLSPVPSAEPATSQDCGVADPDEAEEFLRQFHAEQSDQAVPLTRRLDQVRAAIDATGTYRHTTAELVFGARVAWRNSSRCIGRLYWNSLRVLDRRDTTAPEVIHRHLCTHLRQATNGGRIRPVISVFAPDAPSRPGPRVWNEQLVRYAGHRRDDGTVLGDPRSADLTEAIRGLGWQGGRQGPFDVLPLVIDAHDDKPRFFELPREVVLEVPITHPDVPRLAELCLRWHAVPVISNMRLRIGGVDYPLAPFNGWYMGTEIGVRNLVDEARYNLLPAVAACLQLDTTSESTLWRDRALVELNVAVLHSFAAAGVRISDHHEESRRFLAHLTKEERQGRTVPADWSWIVPPLSSGITPVFHRYYDNADQRPNFYPHQ	MPHFRLALIPLLTAFCLPAFAHPTTLNKVKEAESQLTARVGYAELDLTSGEILESYRLQERFPMMSTFKVLLCGAVLARVDAGKERLDRRIPFSRRDLVEYSPVTEKHLTDGMTVGELCDAAITMSDNTAANLLLTAIGGPQGLTAFLRTTGDRVTRLDRWEPELNEALPGDKRDTTTPENMAQTLRQLLTGKILTTTSQQQLTHWMVTDKVAGPLLRSVLPAGWFIADKTGAGARGSRGIVAALGPDGKPSRIVVIYITESQATMAERNRQIAGIGATLIQHWDE	139.86	gnl|BL_ORD_ID|3561|hsp_num:0	4630			9	180	
BGC0000444.1|Thaxtomin_2 # 1235 # 2269 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.665	BGC0000444.1|Thaxtomin_2 	1235	2269	-	Loose	575	30.4166	SPR-1	30.39	3006996	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPR beta-lactamase	GTGCTGGCCGCGAAGTTCCCCGGGCAGCCACTGCCGCCGGAGAGCATCTTCCACCGCTGGACCAAGAACGTGGTGATGTATACGGACCCGCCGCTCCACGACGCTCTGCGCCGGTCCGTCCACGCGGGCTTCACCCGTTCCGCGCACCAGCACTACGACCAGGTCATCCAGAAGGCCGCGCACGACCTGGTCGCTTCAATCCCGGCCGGTGCCACCGAGATCGACGCCGTCCCCGCCCTGGCTGCCCAACTCCCCCTACGCGCTGCCGTGCACGCCTTCGGAGTCCCCGAGGAGGACCTCGGATTCCTCATTCCGCGCGTGGAGACGATCATGACGTACCACTCCGGTCCGAAAGACCAGCCGGTGACCCAGGGGACAGTTATGGAACAGCTCACCGACCTACACACGTACGCCTTCGAACTCCTCCGGGGCATGCGGGGTAAGGTCCTACCGGACACCGTCATCGCCCGCCTGGCGGCCGCCCAGGATGGTCTGACCGAGACCACGCCGGAACAAACCGTGCATCAACTGGCGCTGGTGTTCATCGCGTTGTTCGCACCCACGACGCCGGGCTCCCTCAGTAGCGGCATGCTCGCGTTCGCCCGCAACCCGCAGCAGATCGAACGCTTCCTGGCGGACCAGGCATGTGTGGACAATACGGCCAACGAGGTCCTCCGCTACAACGCCTCAAACCAGTTCACATGGCGCGTCGCGGCCACGGACGTCGACATGGGCGGCGTACAGATCAAGGCAGGGCAGGCCGTCGCCCTGTTCCTGGGCGCGGCCAACCGGGACCCCGACATGTTCGAGAGGCCGCACGATTTCGACCTCGGCCGTCCCAACAGTGGTCGGCACCTGTCGTTCGGCCAGGGGGTGCACGCCTGTCTCGCCGCGCAGATCGTTTCCCTGCAGTTGAAGTGGTTCTACGTAGCCCTGCTGGGCCGCTTCCCGGGCGTCCGGCCGTCGGGCCAGCCGATCTGGAACGAGAACCTCGAGTTCCGCTCTCTCCGCTCACTGCCGCTCAGCCTCCGCTGA	MLAAKFPGQPLPPESIFHRWTKNVVMYTDPPLHDALRRSVHAGFTRSAHQHYDQVIQKAAHDLVASIPAGATEIDAVPALAAQLPLRAAVHAFGVPEEDLGFLIPRVETIMTYHSGPKDQPVTQGTVMEQLTDLHTYAFELLRGMRGKVLPDTVIARLAAAQDGLTETTPEQTVHQLALVFIALFAPTTPGSLSSGMLAFARNPQQIERFLADQACVDNTANEVLRYNASNQFTWRVAATDVDMGGVQIKAGQAVALFLGAANRDPDMFERPHDFDLGRPNSGRHLSFGQGVHACLAAQIVSLQLKWFYVALLGRFPGVRPSGQPIWNENLEFRSLRSLPLSLR	MKKNLGYLTAMTVALCFGAQAQLNPAQPLSSAPPYSLFEQWAQPVAPFQMFPHVYYVGTRNLSSVLLSTPEGLILIDAALDASAPAIRAHIEALGFNIKDLRYILNSHARLDQAGGIARLQVWSGAKVVASAANAQQLALGGKQDFALGDALSFPPVKVDIIVGEGDSITLGDLKLTALMTPGHLPGATSWLTTLHQGGQSYRLVYADSLATPDYYLIDNKNYPSLVQDIRGSFARLAQQQADIFIVNKGTRFDLDNKMQRLQAGDLDAFVDRQGLQQYVQQSQQTFEAQLKQQQSKM	115.44	gnl|BL_ORD_ID|4591|hsp_num:0	5661			72	315	
BGC0000444.1|Thaxtomin_3 # 3113 # 3445 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=14bp;gc_cont=0.667	BGC0000444.1|Thaxtomin_3 	3113	3445	+	Loose	200	25.0238	RbpA	37.04	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	GTGATCGAGCACGCCGCCATAACCGTCAGCAAAGCCCTGGTCGACCAGGGCTTCAAGGATCAGGTCGTCGCACGCGGCGTCGGCCTGAGAATTGACGTCGAGATAGTCGCACGCAACCCGCAGGTCAAGGGGTTCGTGCCGCAGCCGAAGCGGTGGAGGGTCGAGCAGACCTACGGGATCCTGATACTGCACCGGCGCTTGGTCTGCGACTACGAGCACAGTCCCTCCTCTTCCGCCTCCCGCGTCTACTGGGCGATGACCCACGTCATGACCCGACGCCTCACCGGCGCGCGCGCCACCGCCTGTGCCGCGGCGCAGGCGGTGGCAGTGTGA	MIEHAAITVSKALVDQGFKDQVVARGVGLRIDVEIVARNPQVKGFVPQPKRWRVEQTYGILILHRRLVCDYEHSPSSSASRVYWAMTHVMTRRLTGARATACAAAQAVAV	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	96.49	gnl|BL_ORD_ID|1307|hsp_num:0	1425			192	273	rifampin; rifaximin; rifabutin; rifapentine
BGC0000444.1|Thaxtomin_4 # 3442 # 3639 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.667	BGC0000444.1|Thaxtomin_4 	3442	3639	+	Loose	500	21.9422	APH(3')-Vb	44.83	3002650	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGAACATCCGGCCCCTGCTCGATGCCCTGGACCTCCAGGAAGACGCTGCCCGGGCCCTGGCCGACAACCTCCGCGCACAGATCGACGGCCTGCAGACCCGGTTACGGGAGGCCGAGACGCACCTGGAGCACCTCACGATCACCCGCAAGACCGTGAGCCTTTTTCAACCTCTCGCGTCGGCTGGGCAGTTGGCCTGA	MNIRPLLDALDLQEDAARALADNLRAQIDGLQTRLREAETHLEHLTITRKTVSLFQPLASAGQLA	MESTLRRTYPHHTWHLVNEGDSGAFVYRLTGHGPELYAKIAPRTPENSAFHLDGEADRLDWLARHGISVPRVVERGADDTTAWLVTEAVPGAAASEEWPEDERAAVVDAIAEMARTLHELPVSECPFDRRLDVTGEARHNVREGLVDLDDLQEEPAGWTGDQLLAELDLTRPEKEDLVVCHGDLCPNNVLLDPETHRITGLIDVGRLRLATCHADLALAARELAIDEDPWFGPAYAERFLERYGAHHVDQEKMAFYQLLDEFF	24.71	gnl|BL_ORD_ID|1423|hsp_num:0	1548			417	504	neomycin; ribostamycin; paromomycin
BGC0000444.1|Thaxtomin_5 # 3706 # 4470 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=6bp;gc_cont=0.678	BGC0000444.1|Thaxtomin_5 	3706	4470	+	Loose	1000	28.8758	eptA	31.37	3003576	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCTTGTCTACCCGTCCGGCGTCAACGTGTCCAGCTCTACCCTCCGCTTCCTCGCCACCCGCCTGAGAGAACGTCGGCGCTCTCTCGGCACGCGGTGGCGGCGTCTGAATGCGGGCCGACAGGCCCTGCTCACCCTCGCCCACCTCCGCAACGGNCAGCCCTACGCGCAGCTCGCAGCCGGTTTCGGGATCGGCACCACCACCGCCTACCGGTACATCGCGGAGGCTGTCGAGCTCCTGGCGGCCCTCGCCCCCACGCTCGCCGAAGCAGTACGGGCCGCGTCGACGAAGGCGTACCTGATCCTCGACGGGACGCTTCTGCCGATCGACCGGATCGCTGCCGACCGCCCCTTCTATTCAGGAAAACACAAGAAGCACGGCATGAACGTGCAGGTCATAGCCGATCCGAAGGGCCGTCTCCTGTGGGCTTCACCGGCCCTGGCCGGTGCCGTCCATGACGTGCGGGCCGCCCGCGAGCACGGCATCATCGACGCTCTCGCCGAGGCCGGCATCAACTGCTGGGCAGACAAGGGATACCAGGGCGCAGGCGGCACGGTCCGTGTCCCTTACCGAGGCCGATGGGACAGCCTCTCCGCCGGCCAGCAGGCCGTCAACCGGTCCCATGCGAAGGTCCGGGCACTGGTCNAACAAGCCATCGCCACCCTCAAATCCTGGCGGCTCCTGCGTAAGCTCCGCTGCTCGACGACCCGGATCACGAGCCTCGTCCAANCCGTCCTCACCCTCCATCTGGCCAGCTCAGACTGA	MLVYPSGVNVSSSTLRFLATRLRERRRSLGTRWRRLNAGRQALLTLAHLRNXQPYAQLAAGFGIGTTTAYRYIAEAVELLAALAPTLAEAVRAASTKAYLILDGTLLPIDRIAADRPFYSGKHKKHGMNVQVIADPKGRLLWASPALAGAVHDVRAAREHGIIDALAEAGINCWADKGYQGAGGTVRVPYRGRWDSLSAGQQAVNRSHAKVRALVXQAIATLKSWRLLRKLRCSTTRITSLVQXVLTLHLASSD	MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	46.44	gnl|BL_ORD_ID|595|hsp_num:0	516			906	1056	polymyxin B
BGC0000444.1|Thaxtomin_6 # 4489 # 4728 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.654	BGC0000444.1|Thaxtomin_6 	4489	4728	+	Loose	770	25.409	tet(J)	36.11	3000177	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTGGCGCCACTTCTTCCTCGTTTCCTTGTTCAGGACAACCCTATTGGGTGCCTGTCCGGAAACTTCGTGGCCCCTCATCAAGCAACGGCATTGTGTGCCCGGCGGCAGGTGGCACACGCTGATCTCCAGACCCGTCTCGGTGGCCAGTACGGCGAGGTTGGCCTTCCAGGCCCGGGCGCGGGAGCTGTTCGAGCCGCCGCCGTCCGCGGTGATCAGAAGTCTGCGCGCGTCGGGGTAG	MWRHFFLVSLFRTTLLGACPETSWPLIKQRHCVPGGRWHTLISRPVSVASTARLAFQARARELFEPPPSAVIRSLRASG	MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPILGKLSDKYGRKPILLISLLGAALDYLLMACPTSLWMLYIGRIIAGITGATGAVCASAMTDVTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQETQTTKISTEISALNQDTAPHSTTGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRFAWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVWVMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSYSVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS	19.85	gnl|BL_ORD_ID|1040|hsp_num:0	988			636	732	tetracycline
BGC0000444.1|Thaxtomin_7 # 4963 # 6186 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	BGC0000444.1|Thaxtomin_7 	4963	6186	+	Loose	1900	26.5646	acrD	31.65	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGTACGGAGCGGGCTGTAAAAGTCTGGGCGGGCTGGTTCGATGACTTCTTCGCCTCTTTGGCGGGTGTCTTCGGGCGGGTCGAGCCGCGGCGGATGGCGATGGCCTATGTGAAGGCTCTGGTGGCGCCGGTCGAGCGCAAGAACGGGTGGCAGATCGCCGAGCACGTCGGGCACCCGAGTCCGGACCGGGTCCAGTGGTTTCTGGCCCGCTCGACATGGTGCGCGGATCAACTCCGTGACGCCCTGCGGTCGTTCGTTGTCCAGTTCCTGGCCCGGCCGGACGGGGTGCTGGTACTGGACGAGACGGCGTTCTTGCAGAAGGGCCGGATGTCGGCCGGGGAGGCCCCGCAGTACGCCGGGATCACCGGCCAGATCGAGAACTGCCAGGTCGCGGTGTTCTGCGCGTACGCCACCGACACCGGACGCGGGCTGATCGACCGCGAGTTGTACCTGCCCGCCGCCTGGTGCGCCAACGCCGACCGCTGCCGCACCCAGCACATTCCCCGAGCGCGCGCGAAGGCGGTGGTGACCAAACCGGAACTGGGCCGGCGCATGGTCGAGCGGTGCCGCCGGGCCAAAGTGCCCTTCGGCTGGGTGGCCGCCGACAGCGCCTACGGCCAGGACCGCAAACTCCGTGCCGCACTCGAACGCCGCCGCATCCCCTATGTGATGGCCGTCCCGGTGGACGAGACGGTGTCCACCCATGGCACCGGGCCTTGGCGCGAGGACAAGCTGGCCGCTGGTATCCCGCTGATCTTCGAACGCCGCTCCTGCGGCGTGGGCGCCAAGGGCCTGCGCTCCTACGACTGGGCACTGGCCGACGTCACCTGGCCCGGCGGCGCCGAAGGCGGCCCCCGGCGCGGCCATGTCCACTTGCTGCGGGTCAGGCGCTCGATCTCCGACCCCGGCCAGGTCGCCTACTTCGCCGTGCACGCCAAAGCCGGCACCCCGATCGGCGAGATCGTCCGCGTGATGGGGCTGCGCTGGTCCATCGAAGACTGTTTTGAGACCGCGAAGTCCGACTGCGGCCTGGACCACTACGAGGTCCGCACCTGGGACGCCTGGCACCGCCACATCACCCTTTCGATGGCGGCCCTCGCCTTCCTCACGATCACTGACACCCGCAGCCGCCACCTCCAGGAACCCGACGAGCACGACCTATTGCCCGCACCGGTCCCGGCGCCCGAAAAGGGGGCCCGTCGGGCCGCGTTGAAAAGCTGA	MSTERAVKVWAGWFDDFFASLAGVFGRVEPRRMAMAYVKALVAPVERKNGWQIAEHVGHPSPDRVQWFLARSTWCADQLRDALRSFVVQFLARPDGVLVLDETAFLQKGRMSAGEAPQYAGITGQIENCQVAVFCAYATDTGRGLIDRELYLPAAWCANADRCRTQHIPRARAKAVVTKPELGRRMVERCRRAKVPFGWVAADSAYGQDRKLRAALERRRIPYVMAVPVDETVSTHGTGPWREDKLAAGIPLIFERRSCGVGAKGLRSYDWALADVTWPGGAEGGPRRGHVHLLRVRRSISDPGQVAYFAVHAKAGTPIGEIVRVMGLRWSIEDCFETAKSDCGLDHYEVRTWDAWHRHITLSMAALAFLTITDTRSRHLQEPDEHDLLPAPVPAPEKGARRAALKS	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	39.25	gnl|BL_ORD_ID|1309|hsp_num:0	1427			2439	2634	
BGC0000444.1|Thaxtomin_8 # 6538 # 7485 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.549	BGC0000444.1|Thaxtomin_8 	6538	7485	-	Loose	400	36.5798	mtrA	30.08	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATTGTTCCTGAACTGTTTGTCGCGCTCGCAGTCGAGGAGGGGGAGAATTCCACCTTTACTCGATTCCCGAACAACGTGCCGAACGCAAAGTACCGTCTCTTATCGAGCTCAGGCATTCAGGTAAAATATTTCGAGGCGTGCGAAATCCAGGCGACAGCCGTAGATTCTGGTAAAGCCATCATTGAGTTCGAGGCAGTAAGTTCGGAGGCGACTTTGCCACAGCGGACAGTCGTATGTGCACTGTCGGGCCTTGCATGTATCACGCATGGCAAGGAAAATTCGGAGATCGGCGCGGGGATGCTGGCCATGAACGACGGCAGTGTTCCATTTTCGATCTATGTGCCGGTTGCGGCGCGATTCCTCGTGCTGCGTTTCATCGAGGCGGCGAAGGACGGGCTCCCGATGTCGCCTCGGGGAACTTTCGGCGTGGTAAATCTTACCAAAGATCCCGGATCCGGATTTCTTCTTTCATCCTTGAATGCCCTGGCTGCAGAGATGATGAAAACCGATTTTATTCTACCCCCTGGTATGAGAGAGGTCGTGCGCATCCTAGCGGCCTCGGCGATGAGAACCGCATATATCGAGCTCGGCAAGCAACACTCTGGGGGATTCGACCCACTTCTGATCGCCGTTCAGGAGTCGATCGACCGGCAATTGGCTGATCCTGAGATCAGCCCGGCGACCTTCGCGGCCGAACATAATATATCGGTGCGTCAGTTGCATCGCATTTTCGAATCGATCGGGGAAAGTAGCATGAGCTACGTCAAACGCCGTCGCCTGGAGCGTTTCGCATGCGACCTAAGGAATCCGAGCCTGAGGCACCGAAAGATCAACGAATTGGCGGCGGACTGGGGGATGTTGGATGCCGCGATGCTGAGTAAAAACTTCAGCTCAGCCTACGGAATGTCTCCCCGTGCCTATCGGAAGCAGTACTGCCCCACCTGA	MIVPELFVALAVEEGENSTFTRFPNNVPNAKYRLLSSSGIQVKYFEACEIQATAVDSGKAIIEFEAVSSEATLPQRTVVCALSGLACITHGKENSEIGAGMLAMNDGSVPFSIYVPVAARFLVLRFIEAAKDGLPMSPRGTFGVVNLTKDPGSGFLLSSLNALAAEMMKTDFILPPGMREVVRILAASAMRTAYIELGKQHSGGFDPLLIAVQESIDRQLADPEISPATFAAEHNISVRQLHRIFESIGESSMSYVKRRRLERFACDLRNPSLRHRKINELAADWGMLDAAMLSKNFSSAYGMSPRAYRKQYCPT	MDILDKLVDLAQLTGSADVQCLLGGQWSVRHETLQCEGLVHIVTAGSGYLCIDGETSPRPVGTGDIVFFPRGLGHVLSHDGKYGESLQPDIRQNGTFMVKQCGNGLDMSLFCARFRYDTHADLMNGLPETVFLNIAHPSLQYVVSMLQLESEKPLTGTVSVVNALPSVLLVLILRAYLEQDKDVELSGVLKGWQDKRLGHLIQKVIDKPEDEWNIDKMVAAANMSRAQLMRRFKSQVGLSPHAFVNHIRLQKGALLLKKTPDSVLEVALSVGFQSETHFGKAFKRQYHVSPGQYRKEGGQK	104.65	gnl|BL_ORD_ID|1431|hsp_num:0	1559			507	891	erythromycin; penicillin; azithromycin
BGC0000444.1|Thaxtomin_9 # 7472 # 7645 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.523	BGC0000444.1|Thaxtomin_9 	7472	7645	-	Loose	1500	23.483	LptD	31.82	3005059	protein homolog model	n/a	n/a	peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTCATCACATCTGATCTGCGTCCGGTATTTCGCCCACAGGCAGGTTGCCAACAGGGTTTTCTCGCTCTCGATGGCGGACCCGAATGACCTAAAGATTGAAATTTCAAGCAAATATGGCAGGTGGGCGGCCGGATTCGTTACCTGCGGAGGGTCTCGACATGATTGTTCCTGA	MSSHLICVRYFAHRQVANRVFSLSMADPNDLKIEISSKYGRWAAGFVTCGGSRHDCS	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	7.29	gnl|BL_ORD_ID|2784|hsp_num:0	3799			939	1068	
BGC0000444.1|Thaxtomin_11 # 8229 # 8591 # 1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=GGGG;rbs_spacer=14bp;gc_cont=0.636	BGC0000444.1|Thaxtomin_11 	8229	8591	+	Loose	350	24.2534	Alkalihalobacillus clausii chloramphenicol acetyltransferase	29.27	3004452	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	TTGTCCTGTCGGGCGGTGCGTAAGCTTCGGCGGGATTGGTGGCGGATCCATATGCCCTACTCATTGGACTCGGCTGCCGGCTTTGCCCTGCCAACTGCCCACCCAACCGCACTTACGCGCCACGCTGGAGGGTGCATTTTGAGACAGCGGCCCGCCGGGCAGGCGGAGTCGTCGAGCGCAAGCGCCGCCGATTCGGAAGTCGCAGGCAGCTCCTGTTTTCCCCTGGTCGCGGGAGGCCACTATCCCCGTTTGTTAGCCGAACTCTTTCGGTTGCGGCGAGGCGGCAGGAGCCGTACGTGGATTACCGTCTCACCGTTGCCAAAGAGGAAGCTTGGCGTCCAGATGCAACGACGCGGTCACTGA	MSCRAVRKLRRDWWRIHMPYSLDSAAGFALPTAHPTALTRHAGGCILRQRPAGQAESSSASAADSEVAGSSCFPLVAGGHYPRLLAELFRLRRGGRSRTWITVSPLPKRKLGVQMQRRGH	MEILTLLIRDTMGSKRIFLNPYFQQQPTFSLTNEINITILMKNLKKKHYKLYPAFIFMVTKIVNAHREFRINFNSEGNLGYWTEICPLYTIFDNKSHTFSGIWSPNLTIFSEFHSKYENDAERYNGTRRLFPKKPIPDNPIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDELFLPVSIQNASCLFVMATMQSVFINDLQNLVDESEDWIYLVVSDEWYY	52.63	gnl|BL_ORD_ID|4665|hsp_num:0	2891			423	546	chloramphenicol
BGC0000444.1|Thaxtomin_12 # 8860 # 9624 # -1 # ID=1_12;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.686	BGC0000444.1|Thaxtomin_12 	8860	9624	-	Loose	850	28.1054	hp1181	46.15	3003964	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; nitroimidazole antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCCCGACCTGGCGATGCGGCGGATCGCCGATCTCTACCCGGGCGAGGTGAAGACCGACGCGAAGGACGCCGCAGTGGTCGCGGACGCCGCCCGGACGATGCCGCACACCCTGCGCTCGTTGGAACTGACCGACGAGATCACCGCCGAACTGACCGTGCTGGTGGACTTCGACCAGGACCTGGCGGCCGAGGCCACCCGTACCTCCAACCGGATACGCGGCCTGCTCACCCAGTTCCACCGCAGCCTGGAGCGCGTCCTCGGGCCGCGTCTGGGCCATCAGGCCGTGACCTGGCTGCGGGAACGCTACGGCTTCCCGGCCGCCCTGCGGAAAGCCGGGCGCTGCAAGCTGGTTGAGGTGATCCGGCCCAAGGTTCCGCGCATGGCCCAGCGGTTGGAAGACGAGGTCTTCGACACGCTCGACGAGCAGACCGTCGTGGTCCCGGGCACCGGCACCCTCGATGTTGTGATCCCGTCGCTGGCCCGATCGTTCGCGGCCGTCCACGAACGGCGACGAGCTCTGGAAGCGCAGATCGGGCAGTCGCTGGAGACTCACCCTCTTTTCCCGGTCCTGACCTCGATGCCGGGGGTCGCGGTCAGGACCGCCGCCACCTTGCTGGTCACCGTCGGCGGCGGCAGCAGGTTCCCCAACACCGCTAACCTGGCCTCTTACGCCGGCCTCGCCCCGACAACAAGGTCGTCGGGAACCTNGATCCACGGCGAACGCACGCCCAGAATCGGCAACCGGCAACTCAAGCGCGCATAG	MPDLAMRRIADLYPGEVKTDAKDAAVVADAARTMPHTLRSLELTDEITAELTVLVDFDQDLAAEATRTSNRIRGLLTQFHRSLERVLGPRLGHQAVTWLRERYGFPAALRKAGRCKLVEVIRPKVPRMAQRLEDEVFDTLDEQTVVVPGTGTLDVVIPSLARSFAAVHERRRALEAQIGQSLETHPLFPVLTSMPGVAVRTAATLLVTVGGGSRFPNTANLASYAGLAPTTRSSGTXIHGERTPRIGNRQLKRA	MFKKIFPLALVSSLRFLGLFIVLPVISLYADSFHSSSPLLVGLAVGGAYLTQIVFQTPMGILSDKIGRKVVVMVCLLLFLAGSLVCFIANDIVWLVIGRFIQGMGALGGVISAMVADEVKEEERTKAMAIMGAFIFISFTISMAIGPGVVAFLGGAKWLFLLTAILTLLSLLMLLKVKDAPKISYQIKNIKAYQPNSKALYLLYLSSFFEKAFMTLIFVLIPLALVNEFHKDESFLILVYVPGALLGVLSMGIASVMAEKYNKPKGVMLSGVLLFIVSYLCLFLADSSFLGKYLWLFIVGVAFFFIGFATLEPIMQSLASKFAKVHEKGKVLGQFTTFGYLGSFVGGVSGGLSYHHLGVSNTSLIVVALGLIWGLSLFLLNNPSKQKNVYFPLDAYNEEQFETLEDKIIEWYVNISEEIIIVKYNSDHISEEEIIHLAQNFRK	57.34	gnl|BL_ORD_ID|2191|hsp_num:0	2430			918	996	ciprofloxacin; tetracycline; metronidazole
BGC0000444.1|Thaxtomin_13 # 9675 # 9818 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.660	BGC0000444.1|Thaxtomin_13 	9675	9818	+	Loose	700	21.9422	CMA-2	35.0	3006923	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CMA beta-lactamase	ATGGAGGCGGGCTCGTTCACGATCACCAGGACGGTCCCGACCTTCGCGGCCAGCTTGCCGAAGACCGCCCGCAACTTGGGCTCGCTGTTAGGCAGCTGTTTGTCGAAGACCTTCTTGCCGGCCGGCGTGAGCCCGTGCCCGTGA	MEAGSFTITRTVPTFAASLPKTARNLGSLLGSCLSKTFLPAGVSPCP	MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVASKATRKPVDEKTLFEIGSLSKTFTATLASAAQQEGKLDFSAPASQYLPALKGSAFDHVTLLNLATHTSGTPLFVPDAVKNTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALDKPFSEAMEQGLLRDFGMTHTFINVPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPRWRQAINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLVEGNSSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSSYAVFIPEKRIALIMLANKWFPNDDRVKAAYAIIQQLDK	12.53	gnl|BL_ORD_ID|3393|hsp_num:0	4462			207	327	
BGC0000444.1|Thaxtomin_14 # 10108 # 14568 # 1 # ID=1_14;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000444.1|Thaxtomin_14 	10108	14568	+	Loose	1000	114.005	almE	27.61	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGCAGGACCGCGAAAAACATAACGGGAATTCCCGGTGCCATGAAACCTGCTTTACCGGGATGAACGGTACATCCGAGGACGACAGAGAGGAACGGATTCCCGTGTCACACCTGACGGGTGGAGATCGACCTGAGGGAGCGCTCGCCACGACGTGGCCGAGTCTCCTCGAAGCGTGGGCGGCCGACACACCTGACGCCATCGCGCTTGTCACTGCGGACACGGCACTCACGTACGCGCAGTTCAATGCCCGTGCGAACCGGCTTGCCCGTTGGCTGAAACACCTCGGCGCCGGACCGGAGCGGTCGGTCGGGCTGGTGCTGGGCAGGTCCGCAGACTTCTTCCTGTGCGCGACTGCCGTGCTCAAGTGCGGGGCGGCGTACCTTCCGCTGGATCCGAGCTACCCCATGGAGCGGCTGTCCTTCATGACCCGGGACGCGGCACCCGTTGCGCTGGTGACGACATCGGACGTCCCGGGCGAACTCCTGGACCAGCTGTCCACCCGACGCCTCGTGTCGCTGGACGATGAGGTAGCCGAGGACGCATTGCGCCGTCTGCCGGACCACGACATGGAGGACGGGGAACGCCTGGAGCCACTGCGCCCTGCGAGTCCCGCCTACATCATCTACACCTCCGGGTCCACGGGGATCCCAAAGGGAGTCGTCGTCACCCACCAGGGCGTCGCGAGCCTGATCGCGACCCAGCGTCGTCGCCTCGCCGTCACCGGCGTCTCACGCGTGCTCGCCTTCTCGTCCCCGAGTTTCGACGCCAGTTTCTGGGAGATGTCGATGGCGCTACTCACCGGAGCCGCGCTCGTGGTCGGCAGGCCGGGACGGCTGCTGCCTGACACCGAACTGGCCGCGCTGATCGCGGACCAGGGAGTTACCCATCTCACTCTCCCGCCCTCAGTCGCGGGTTCGCTGGATCCCGGCATGTTGCCTCCGGGTGTGACGCTGGTCGTCGCGGGCGAAGCATGCCCGGCAGCTCTCGTACAGCGCTGGCGCCCGCACCGGACGATGGTGAACGCCTACGGCCCTACCGAGTCCACCGTCTGTGCCACCATGAGCGATCCGCTGGCCGACGACATGGCGCCGCCGGTCGGCCGGGCAGTGGACGGCACCCGGATCCATGTCCTCGACGATCGCCTCGCACCTGTTGTGTCGGGAGCGGTTGGCGAGATCTTCATCGCGGGGCACAGCCTGGCCCGCGGGTACCTCAAGCGGCCGGGTCTGACCGCTCAGCGGTTCGTGGCGGACCCCTTCGGCCCGGCCGGCAGCCGTATGTACCGCAGCGGTGACCTCGGCCGCTGGACCCGTTCAGGAGAGCTGGAGTTCGTCGGCAGGGCGGACGACCAGGTCAAGGTACGCGGCTTCCGTATCGAGCCGGGTGAGATCGAATCCGTCCTCGCCGGGTGCCGCGGGGTCCGGCAAGCCGCCGTCGTCGTGCGCGAGGACCGGCCGGGAGAGCCGTACCTCGCCGCCTACGTCGTACCCGAGAACGAGGCCGCCGACGAGACGGCCGAGGAAGAACTGGACGGTCGACTCGCCGCCTGGCGACGGCTTTACGACGATCTGTACGACCGGGCAGACACCCCCGACTTCGGCGAGGACTTCTCTGGCTGGGTGAGCAGTTACGGTGGGCGGCCGATCGAGGGGATGCGAGAGTGGCGTGCGCAGACCGTGCAGCAGATCCGCGAACTGGCTCCGCGCCGTGTACTGGAGATCGGCTGCGGTTCCGGTCTGCTGCTCTCGCAGCTGGCGGGCGACTGCGAGAGCTACTGGGGCACCGACATCTCTGGGGCTCTGATCGAGCGGCTGCGCGGGCAGGTCGCTGAGCGCCCTGGCCTCGCAGACCGGGTCGTCCTGCACCGGCTCTCCGCCCATGAGCTGGGGGGTCTGCCCCGCAGTGGCTTCGACACCGTCGTGCTCAACTCCGTTATCCAGTACTTTCCTTCGGGCGACTACCTGTTCGACGTACTGCGTGAGGTGTCTGGGCTCCTTGCACCCGGGGGGGCGGTGTTCCTCGGTGACGTCCGCAACCTTCGTTTGTTGCGCACCTTCCACACTGGGGGGCTGCTGGCGTCGGCCTCGCCCGCCGACATTCCGGAGACGGTGTGCGCGGCTATCGACCGGGCCATGGCACAGGAGAGGGAACTGCTCGTGGACCCGGAGTTCTTCGCGACGGTCGTCGGCGCGCTGCCTGGCATGACGCTGGAGTCGTGCACGCTCAAACGGGGCGGTTATGACAACGAACTCAGCCGCTATCGCTACGAGGTGGTGCTGCGCAAGCACGCCGGGCCCGCGGACGACCCGGGGCCGGTCGTGCGGCTGCCGTGGGACGGCGGGACGGCGAGCCTGGCCGGCGTCGCCGATTGGCTGCGCCGTGGGAAACCAGAGCGGGTGTGCGTCACCGGAATACCGAACGGCCGGGTGGCCGGCGAGCATGCCGCGACACTCGCGCTGTTCGACCGGCGCCCCCTGCCCGAGGTGTTGTCCCTGGGGCAGGTTCCGGCTGGTGTGGCACCGGAGGACCTGCGCCAGCTGGGCGCGGAACTGGGCTACCGGGTCGACTGCGCATGGTCGTCCGAGAACGACGCCTTGATCGACGCCTCCTTCACCCTCGCCGGAACGCTCGTGCCGCGTCCCGCCCCCCGGACCGACGCTAAGCCGGACGACTTCTCCCCGGCCAGGTTCACCAACAGGCCGGCGTTCGCCCGCCCTGACTCCCGGACGATGGCCTCACTTCCCGGGCAGGTGGCGGCGCAGCTGCCAGCCTTCATGGTCCCCGAGGTCTTCGTCCCGCTCGACAGGCTGCCGGTCACGGTGAATGGAAAACTCGACCGCGCCGCCCTGCCCCGGCCGCAGCGCGCCGCCCCTGCCGCGGGACGTCCGCCCAAGACCGCCCGCGAGGAGGTACTCGCGGCGATCTTCGCCGACGTACTCGCGACCGCCGACGTCACAGCCGACAGCGACTTCTTCGCCACCGGCGGCAACTCCCTGCTGGCCACCCGCCTCGCCGCCGAGGTCCGGCACCGCCTGGACACCGAGATGCCGCTGTCGTGGCTGTTCGAGTCGCCCACCGTCGAGGCGCTCGCCGCCCGCTTCGACGCAGAGGACGAGGCTAGGCCGGTGCCCGTGCCGGGCGAGTACGCCTCCGGCAGCACGGCACCGTTGTCGGCCCAACAACTGCAGATGTGGGACGAGTACCGCCAAAGCCTGCACAGGGACATGTTCAATGTACCGCTGTCGCTGCGGCTGACTGGTGCCGTCGACGCTGAGGCACTGCGCGCCGCCTTGGCCGACGTCGTCACCCGGCACGTTCCGCTGCGCACGCTCGTCCGGGACGACGGTAGCGGTCCGTGCGCGGTGATCACGGAAGCCACCGCGGACGACATCCCCTGGACGCAGACCAGGACGACACCCAAGCGGCTGCCCGAGGATCTCGCGCACGCCGCCCGCCGCCACTTCGACCTCGAAACCGAGATCCCGCTGCGGGCCGCACACTTCACGCTCGGCCCGAACGAGTCCGTACTGCTGCTGGTCATGCATCACATCGCCGCCGACGGCTGGTCCTTCGGCCCCCTGCAGGAGGACCTGGTGCGCGCCTACCGCTCCAGGACCGAGGGACACGCACCACAGTGGGAGCCGCTGTCCCTCGGCTACCTCGATTACGTCGCCTGGCAGCGCCGACTCCTCGGCTCCCCGGACGACCCGAGCGATGTCGCGCTGCGCCAGGCCGAGTACTGGAGGAAGACACTGCACGGTGCCGACGACAGGCCGGTCCTGGAGACCGACAGCCCGGCGCCGTCCCGGCAGGACTTCGCCGGTAGGTCCCTCGACCTTCCACTCGAAGTCGGCGGCCACCGGGTGCTGACAGCCGCGGCTCGTGAACACGGTGTCACCGTCTTCATGATCCTGCACGCGGCGCTCGTCGCAATGCTCGCCCGAAAGGGGGCGGGAGGAGACATCACCGTCACGACCGCGGTGGCTGGCCGGACCGACACCCAGTTCGAACCGCTCGTGGGCCTCTTCGCCAACACCCTGGCCCTGCGCATCGACACGTCGGGCAACCCCACTTTCCGTGAACTTCTGTACCGGGTCCGCGTGACCGATCTCGCTGCCTACGCCCATCAGGACCTGCTCTTCGAGCACCTGGCCGACATGCCATCGCCGCAGGTGTCACTCGTCCTGCGCACGGTCGCGGCCCCGCCCTCCGACCTGCCTGGCCTCACTCTCGCTCCCGGCCCACGACCCGCGAGCGAATCCGCCCGCTATCCGGTGCTGTGGACCGTGGAGCACCTGGCCTCCACCGCCGACAGCGGGACGCTGCGCAGCCACATCCAGTACCAGAGCGGGCTGCTGCGCGACGACACGGTCGCCCGGATCGCCCAGCGGTACGAAGTCGTGCTGTCCCTGTTGCTGAAGGATCCGGACCTCCGCGTCCAAGACCTCCCACCGCAGTGA	MQDREKHNGNSRCHETCFTGMNGTSEDDREERIPVSHLTGGDRPEGALATTWPSLLEAWAADTPDAIALVTADTALTYAQFNARANRLARWLKHLGAGPERSVGLVLGRSADFFLCATAVLKCGAAYLPLDPSYPMERLSFMTRDAAPVALVTTSDVPGELLDQLSTRRLVSLDDEVAEDALRRLPDHDMEDGERLEPLRPASPAYIIYTSGSTGIPKGVVVTHQGVASLIATQRRRLAVTGVSRVLAFSSPSFDASFWEMSMALLTGAALVVGRPGRLLPDTELAALIADQGVTHLTLPPSVAGSLDPGMLPPGVTLVVAGEACPAALVQRWRPHRTMVNAYGPTESTVCATMSDPLADDMAPPVGRAVDGTRIHVLDDRLAPVVSGAVGEIFIAGHSLARGYLKRPGLTAQRFVADPFGPAGSRMYRSGDLGRWTRSGELEFVGRADDQVKVRGFRIEPGEIESVLAGCRGVRQAAVVVREDRPGEPYLAAYVVPENEAADETAEEELDGRLAAWRRLYDDLYDRADTPDFGEDFSGWVSSYGGRPIEGMREWRAQTVQQIRELAPRRVLEIGCGSGLLLSQLAGDCESYWGTDISGALIERLRGQVAERPGLADRVVLHRLSAHELGGLPRSGFDTVVLNSVIQYFPSGDYLFDVLREVSGLLAPGGAVFLGDVRNLRLLRTFHTGGLLASASPADIPETVCAAIDRAMAQERELLVDPEFFATVVGALPGMTLESCTLKRGGYDNELSRYRYEVVLRKHAGPADDPGPVVRLPWDGGTASLAGVADWLRRGKPERVCVTGIPNGRVAGEHAATLALFDRRPLPEVLSLGQVPAGVAPEDLRQLGAELGYRVDCAWSSENDALIDASFTLAGTLVPRPAPRTDAKPDDFSPARFTNRPAFARPDSRTMASLPGQVAAQLPAFMVPEVFVPLDRLPVTVNGKLDRAALPRPQRAAPAAGRPPKTAREEVLAAIFADVLATADVTADSDFFATGGNSLLATRLAAEVRHRLDTEMPLSWLFESPTVEALAARFDAEDEARPVPVPGEYASGSTAPLSAQQLQMWDEYRQSLHRDMFNVPLSLRLTGAVDAEALRAALADVVTRHVPLRTLVRDDGSGPCAVITEATADDIPWTQTRTTPKRLPEDLAHAARRHFDLETEIPLRAAHFTLGPNESVLLLVMHHIAADGWSFGPLQEDLVRAYRSRTEGHAPQWEPLSLGYLDYVAWQRRLLGSPDDPSDVALRQAEYWRKTLHGADDRPVLETDSPAPSRQDFAGRSLDLPLEVGGHRVLTAAAREHGVTVFMILHAALVAMLARKGAGGDITVTTAVAGRTDTQFEPLVGLFANTLALRIDTSGNPTFRELLYRVRVTDLAAYAHQDLLFEHLADMPSPQVSLVLRTVAAPPSDLPGLTLAPGPRPASESARYPVLWTVEHLASTADSGTLRSHIQYQSGLLRDDTVARIAQRYEVVLSLLLKDPDLRVQDLPPQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	267.27	gnl|BL_ORD_ID|4935|hsp_num:0	5928			300	1437	colistin A; colistin B
BGC0000444.1|Thaxtomin_15 # 14565 # 19082 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000444.1|Thaxtomin_15 	14565	19082	+	Loose	1000	123.25	almE	30.36	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAATCCCAGGGCCAGCCCGTCCGATCCCATCCTCTGTGAGGTCCACTCGATGTCCACGCTGCCGCCGGGGCGAAGCCGTACCACGGCCCCGCCCGCCGGGCCCCAGGCCAGCCCCGAGTTCACCCCCGACCTGTGGGGACGGCTCTTCGAAGCCCGTGTCGACGCCGACCCCGAATCCACCGCGATCAACTCCGCGAGCGATCGGCTGAGTTACGCCGAACTGAACTGGCGGGCCAACCGCCTGGCCAGACTGCTCGTCGCACATGGCGCCGGCCCGGAGAGCCTGGTCGGTATCGCCCTGCCGCGCTCGACCGACTTCGTGGTGGCCGTGGCGGCCGTACTGAAGTCGGGCGCCGCCTACTTCCCGCTGGACCCGGAATATCCTCCGCAACGGCTGGCGTTCATGCTCGCCGACGCCGCTCCCCTGCTGGTTCTGACCAGAAGCGACATCGAGCCCGAGCTGCCGGCCGAGGCGGCCTCCCGCACGGTGGTCCTGGACGACCCGGCCGTCGTACGGACCCTGACCGACCGCTCCGCAGCGGACGTGACCGACGACGAACGCGTCGCCCCGCTCCGGACCTGGCATCCGGCCTATGTCATCTACACCTCGGGTTCCACCGGTACTCCCAAAGGGGTGGTCCTCACCCACCACGGCATCGCTGGCCTGGTGGGCAGCCATGCGCGAGACCTGGGGATCGGGGCGTCCAGTCGGCTCCTGCTCTTCTCTTCGCCGAGCTTCGACGGCGCCTTCTGGGACGTGTCGATGGCTCTACTCACTGGCGCCACGCTGGTGGTCGCGCCACGTGAACGGCTCCTGCCCGGACCGGAGTTCAGCGCACTCGTTGCCGAGGAGGGCATCACCCACTTCGCCCTGTCGGCCTCCACACTCTCCGCCCTGCCGGACGGCGCTCTGCCCGCCGGGGCCACCGTCGTCAACGTGGGCGAGGCATGCAACGGCGAGCTGGTACGCCGCTGGTCGCCGGGTCGGCTGATGGTGAACGCGTACGGGCCGACCGAATCGACCGTCTCCGCGACGATGAGCGGACCGCTGGCCGCGGAAGGCATGCCGCCCATCGGCCGTCCGCTCTCGGACACCCGCGTACACGTGCTCGACGAGCGGCTCCGGCCGGTACCGCCGGGGGCGGTCGGAGAGATCCACATCGCCGGAGCGGGGCTGGCCCGCGGGTACCTGGGGCGACCCGCGCTGACTGCTGAGCGGTTCGTGGCCGATCCCTTCGGGGCGCCGGGCAAGCGGATGTACCGGACAGGTGACCTGGCGCGGGTGCGTGACGATGGGCAGCTGGAGTTCGTGGGCAGGGTCGACGACCAGGCGAAGATTCGGGGTTTCCGCGTGGAGCCCGGCGAGGTCGAAGCCATGCTGCGCGACCATCCCGAGGTCGCGCAGGCTGCGGTGCTGGTCCGGGAGGACACTCCGGGAGACCAACGGCTCGTCGCCTATGTCGTGCCGGACCACCCGGCCGTTCGTCAGGNCGACGGCACCGCCTCGGAGCACGTCGGAGAGTGGCAACGGCTCTACGACGAGGTCTACAGCACGGTAGGAGCGCTNCCTCTGGGTGAGGACTTCAGCGGATGGAACAGCTCCTACGACGGCGATCCCATTCCCCTGCCGCAGATGCGAGCCTGGCGGGATGCCACGGTCGACAGCATCCGTGCCCTGCGACCGCGCCGAGTACTGGAGATCGGCGTGGGCACCGGGCTGCTGCTGTCCCACCTCGCCGGTGACTGCGAGGCGTACTGGGCCACCGACTTCTCCACCGAGGTGATCGAGGCACTCGGCAAGAAAGTGGACGGCGACCCGGTCGTGCGCGAGACGGTCCANCTGCGGCCCGGCCCCGCACACAACCTCCCCGGCCTCCCAGAAGGATACTTCGACACCGTTGTCCTCAACTCGGTGATCCAGTACTTTCCGTCGGCCGACTACCTGGTGAGCGTCCTGCGCGAGGCGGTACGCCTCGTGGCGCCGGGCGGCCGGGTGTTCGTCGGCGACGTCCGGCACTTGCGTCTGCTGCGCCCGCTGCGCAGCGCCGTCCGGCTGCGCTCCGCCATCGGGCGGGAAGTCTCGGCNTCCGACGTCCGTGCGGCGGTCGACCAAGACTTGATGGACGAGAAGGAGTTGCTCCTCGATCCCGCATTCTTCACGGTCGTATCCCGGTGGATTCCGCAGATCCGCGGGGTGCGCACAGCGGTGAAGCGCGGCACGCACCACAACGAACTGACCCGTTACCGGTACGACGCGGTGCTCATCAAGGAGCCGGTGAAAACCGGTACTGTCGCGCCGGACGCGCGGACCCTGACCTGGGGCACGGATGTCGGTGGACTGCAACCGTTGTCCGGCCTGTTGGCCCGCATCCGTACGCCACTGCTGCTGCGCGGCGTACCGAACAGCCGGATTCTCGCTGAGGTCTCGGCTGCGGCGGCGCTGGCCACGGCCCCGTCGCTCGACGAACCGTCGCGGTTGCTGCGCGAACCGGCGACCGGGATCGACCCCGAGGAACTGCACGCCCTGGGCGAAGGTGCTGGCTACGAGGTCCACCTCACATGGTCAGCGCAGGACCCCACGCGAGTGGACGCACGGTTCACACCCGCGGGCGGTGAACCGGACGCCGTCCCGCCGGCGGACTCCGCCGACAGTGTCAGGACGTCCCCCGGTGACCACGCCAATCAGCCGACCACGCACCGGACCGGCATGGCTCTGATGAGCAAGCTCCCCGGTTATCTGGCCGCCAGGCTCCCCGCGTACCTGCGGCCTAGCGCCCTGGTACGTGTCGAGTCGCTCCCCCTCACCGTCAACGGCAAGCTCGACCGCGCGGCGCTGCCCCCTCCCCTGCTGTTCCCGCAGGCCGACGGGCAGGCACCCCGCACTCCGCGCGAGGAGATCCTCACCCATCTCTTCGCCGATGTGCTCGGCCTGCCTGGGGTGCCGAGGGACGCCGACTTCTTCGCCCTGGGCGGCAACTCGCTGCTGGCCACGCGCCTCGTCGGCCGCATCGCGAAACACCTCGAAGTAGATGTTCCGATCGCCTGGGTCTTCGAGACACCGACCGTCGAGGGCCTGGCCGGGCGTACCGCGCCGACGAGCAGGTTCCGCCGACGGCTGGTCTGCCGCGACGAGCACCACACGGCGGTGCCGCTCTCGCACAGCCAGTACGGCATGTGGTTCATCAACCAGCTCGGCGGACCCGCGAGCCGGATCTACAACGTGCCGTACTGCCTGCGGCTCACGGGCCGGGTGGACTCCGCGGCGTTGCGGATCGCACTCGACGACGTCGTGGCTCGTCATGAACCTCTGCGCACTGTCTTCCCCGACGACGGTGACGGCCCCCGCCAGCGGGTCCTCGCCCCCGAGGACGCCGTGGTGGTCCTCCATGAGACCGATACCTTCGAAGACCGTCTCGCCGGCGAACTGTCACGGGCCGCGGCGGAACCCTTCGAGCTCAGGACGGACCTTCCCCTACGTGCACGCCTGTTCCGGCACGGCCAGGACCGGTCCACGCTGCTGCTCCTGATGCACCACATCACCGTGGACGCCTGGTCACTGGCCCCCCTGACCGCTGACCTGACGCGTGCCTACCGTGCTCGGCTCGGGCAGCGGGCCCCGCAGTGGCAGCCGCTGCCGGTCCACTATCGCGACTACGCCGTATGGCACAACGCCCAGGTAGCCGGGACCCAGGACCGCAGCAGCGGCTTCGGGCGCGGGCTCGCCTTCTGGGAGCGGATGCTGCGAGGTCTTCCGGTCGAGATGCAACTGCCGGTCGACCGGCGCCGGCCAGCCAGACCCACCTACCGTGGCGGCACCGTCCATACCCGCATCGAAGCCTCCCTCCACCAAGAACTGCTCAACTGCGCGCGGGAGACGGGCGCGACGCCCTTCATGGTGCTGCACGCTGCGCTCGCGGCACTGCTGACCCGGCTGGGCGGCGGCACCGACATTGTCGTCGGCACCGCTGCCGCAGCACGCACGGACCCCGCGCTGGACGACCTCGTCGGGCTGTTCGCCAACAGTGTCGTCCTTCGCGTCGACACTTCGGGCGACCCGACATTCCGCACTCTGCTTGCCCGTGCCCGTGCCGTGGACCTCGACGCCTTCACCCACCAGGAGGTCCCCTTCGACCAGGTGGTGGATCTCCTCAACCCGGCACGCCACCCGGCACGTCACCCGCTCTACCAGACGGCCCTCGTCCTCCACACACCGCCCGGCGACGGCCATCGAGCCCACCTCGTCACCCTCACCCCCGAACCGCCCCCGGACACCGGAACGGCCCGCTTCGATCTGATGTTCAACTGGGACGAGAACCGGGACAGCGCCGGCCTTGCCCAGGGCCTCACCGGCCGCACCGAGTACAGCTCGGATCTCTTCTCCCAGGAGACGGTCGAACTGCTCCTGGAGCGGTATGTCCTGCTGCTGTCCGCAGTGGTCCGCGAGCCGGACACACGCCTTCACACCCTGAACATCCTCACCGAGCCGGAACGGCAGGCCTTCTCACGACGGCCGTAG	MNPRASPSDPILCEVHSMSTLPPGRSRTTAPPAGPQASPEFTPDLWGRLFEARVDADPESTAINSASDRLSYAELNWRANRLARLLVAHGAGPESLVGIALPRSTDFVVAVAAVLKSGAAYFPLDPEYPPQRLAFMLADAAPLLVLTRSDIEPELPAEAASRTVVLDDPAVVRTLTDRSAADVTDDERVAPLRTWHPAYVIYTSGSTGTPKGVVLTHHGIAGLVGSHARDLGIGASSRLLLFSSPSFDGAFWDVSMALLTGATLVVAPRERLLPGPEFSALVAEEGITHFALSASTLSALPDGALPAGATVVNVGEACNGELVRRWSPGRLMVNAYGPTESTVSATMSGPLAAEGMPPIGRPLSDTRVHVLDERLRPVPPGAVGEIHIAGAGLARGYLGRPALTAERFVADPFGAPGKRMYRTGDLARVRDDGQLEFVGRVDDQAKIRGFRVEPGEVEAMLRDHPEVAQAAVLVREDTPGDQRLVAYVVPDHPAVRQXDGTASEHVGEWQRLYDEVYSTVGAXPLGEDFSGWNSSYDGDPIPLPQMRAWRDATVDSIRALRPRRVLEIGVGTGLLLSHLAGDCEAYWATDFSTEVIEALGKKVDGDPVVRETVXLRPGPAHNLPGLPEGYFDTVVLNSVIQYFPSADYLVSVLREAVRLVAPGGRVFVGDVRHLRLLRPLRSAVRLRSAIGREVSXSDVRAAVDQDLMDEKELLLDPAFFTVVSRWIPQIRGVRTAVKRGTHHNELTRYRYDAVLIKEPVKTGTVAPDARTLTWGTDVGGLQPLSGLLARIRTPLLLRGVPNSRILAEVSAAAALATAPSLDEPSRLLREPATGIDPEELHALGEGAGYEVHLTWSAQDPTRVDARFTPAGGEPDAVPPADSADSVRTSPGDHANQPTTHRTGMALMSKLPGYLAARLPAYLRPSALVRVESLPLTVNGKLDRAALPPPLLFPQADGQAPRTPREEILTHLFADVLGLPGVPRDADFFALGGNSLLATRLVGRIAKHLEVDVPIAWVFETPTVEGLAGRTAPTSRFRRRLVCRDEHHTAVPLSHSQYGMWFINQLGGPASRIYNVPYCLRLTGRVDSAALRIALDDVVARHEPLRTVFPDDGDGPRQRVLAPEDAVVVLHETDTFEDRLAGELSRAAAEPFELRTDLPLRARLFRHGQDRSTLLLLMHHITVDAWSLAPLTADLTRAYRARLGQRAPQWQPLPVHYRDYAVWHNAQVAGTQDRSSGFGRGLAFWERMLRGLPVEMQLPVDRRRPARPTYRGGTVHTRIEASLHQELLNCARETGATPFMVLHAALAALLTRLGGGTDIVVGTAAAARTDPALDDLVGLFANSVVLRVDTSGDPTFRTLLARARAVDLDAFTHQEVPFDQVVDLLNPARHPARHPLYQTALVLHTPPGDGHRAHLVTLTPEPPPDTGTARFDLMFNWDENRDSAGLAQGLTGRTEYSSDLFSQETVELLLERYVLLLSAVVREPDTRLHTLNILTEPERQAFSRRP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	270.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1404	colistin A; colistin B
BGC0000444.1|Thaxtomin_16 # 19436 # 20623 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.649	BGC0000444.1|Thaxtomin_16 	19436	20623	+	Loose	200	31.5722	vanT gene in vanN cluster	40.91	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGAATCTACGCCCGACCAAGCCCACCCTACGAACTCACCGTTGGAGCCCTATCACATCTACCCGGAGGCCAGGTCCTGTCCGGTGGCGAAGGTCAGCCTGTGGAACGGCACACCAGCGCACGTGTTCTCCGGGCATGACGAGGTGCGGACCGTGCTACAAGACAGGCGGTTCAGCTCAGACTCGCGACGGCCCAACTTCACCGAACTCACTCCGACGCTCCAATCGCAGGCCGCGCAACCGCCGTTTGTACGCACCGACAACCCTGATCATCGGCGCCTACGGGGCACCGTCGCCCGTGAGTTCCTGCCCAAGCGCATCGAGCTGCTGCGCCCCGCGATCCGCGAGATCGTCCAGGGTGTGCTCGACAGGCTCGCCGAGACCGCACCTCCCCAGGACATGTTCGAGGCCTTCGCCGTCCCCGTGGCGTCCGCGACCGTCTTCCGGCTGCTGGGGATTCCGGCCGAGGACCGCGCATTGCTCACCCGATGCGTCAAGGGCGTGGTTTCGGCGGTGGGGAGCGAGGACGAAGGTGCTGAGGTGTTCAGGATACTCGGCGAGTACATCGGCGGCCTCGTCCAAGACTCCTCCGCACTGCCCGAGGACAGCATGATCCGGCGTTTGGTGGAGGGCCCGTACTCCGCGAAGGAGCTCACCTTCCACGAGGCCATCGGCGTGATCCTCATGCTCATCGTCGGCGGTTACGACACGACGGCGAGCACCATTTCGCTGTCCTTGGTGAGTTATGCGCTGCACCCGGAGAAGTTCTCCTTCGTCCACGAACGGCCGGAGCGGATCCCCATGCTCGTCGAGGAGTTGCTGCGCTATCACACTGTCGCGCAGCTCGGGCTGGGCAGGATCGCCACCGCTGACGTCGAGGTGGGCAGTGTCACGGTGCGGGCCGGCGAGATGGTGGTGGCCGCGCTCTCGCTGGCCAATCGAGACAAGAGTGTCTTTCCTAACCCGGACAAACTCGACTTCGACCGCCCGTCCGTTCCTCATGTCGGCTTCGGCTACGGACCACACCAGTGCGTCGGCCAGGCGCTGGCCCGTGTCGAACTTCAAGAGGCCATTCCTGCCGTGATCCGACGACTGCCCGGCCTGCGGCTCGCCTGCACTCTGGAAGACCTTCCATTCCGGCACGACATGTCCACCTACGGCGTCCATGAGCTGCCTATGACCTGGTGA	MESTPDQAHPTNSPLEPYHIYPEARSCPVAKVSLWNGTPAHVFSGHDEVRTVLQDRRFSSDSRRPNFTELTPTLQSQAAQPPFVRTDNPDHRRLRGTVAREFLPKRIELLRPAIREIVQGVLDRLAETAPPQDMFEAFAVPVASATVFRLLGIPAEDRALLTRCVKGVVSAVGSEDEGAEVFRILGEYIGGLVQDSSALPEDSMIRRLVEGPYSAKELTFHEAIGVILMLIVGGYDTTASTISLSLVSYALHPEKFSFVHERPERIPMLVEELLRYHTVAQLGLGRIATADVEVGSVTVRAGEMVVAALSLANRDKSVFPNPDKLDFDRPSVPHVGFGYGPHQCVGQALARVELQEAIPAVIRRLPGLRLACTLEDLPFRHDMSTYGVHELPMTW	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	56.43	gnl|BL_ORD_ID|4745|hsp_num:0	1983			822	948	vancomycin
